Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.125 SEK | +18.06% | +23.55% | -17.64% |
Apr. 13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
Apr. 12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Sales 2024 * | 10M 945K | Sales 2025 * | 116M 10.97M | Capitalization | 179M 16.89M |
---|---|---|---|---|---|
Net income 2024 * | -115M -10.87M | Net income 2025 * | -60M -5.67M | EV / Sales 2024 * | 10.5 x |
Net cash position 2024 * | 73.52M 6.95M | Net cash position 2025 * | 45.95M 4.34M | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.74
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Biovica International AB
1 day | +18.06% | ||
1 week | +33.31% | ||
Current month | +33.31% | ||
1 month | +24.56% | ||
3 months | -5.35% | ||
6 months | -27.84% | ||
Current year | -17.64% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 22-12-31 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-03-19 | |
Annika Berg
BRD | Director/Board Member | 61 | 19-12-31 |
Maria Holmlund
BRD | Director/Board Member | 68 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 2.125 | +18.06% | 734,960 |
24-05-27 | 1.8 | +0.45% | 128,133 |
24-05-24 | 1.792 | +2.40% | 674,697 |
24-05-23 | 1.75 | +1.16% | 140,018 |
24-05-22 | 1.73 | +0.58% | 279,117 |
Delayed Quote Nasdaq Stockholm, May 28, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.64% | 14.26M | |
-36.44% | 9.2B | |
-3.29% | 3.12B | |
+19.31% | 2.8B | |
-18.71% | 2.07B | |
-22.03% | 1.59B | |
+64.58% | 1.44B | |
+34.58% | 830M | |
-7.42% | 724M | |
-25.51% | 507M |
- Stock Market
- Equities
- BIOVIC B Stock